Results 111 to 120 of about 3,590 (195)
Endocrine toxicities in immune checkpoint inhibitors and tyrosine kinase inhibitors combined treatment: from clinical trials to real-life practice. [PDF]
EndocrineChiloiro S, Maratta MG, De Sanctis SA, Costanza F, Rossi E, Vita E, Giampietro A, Pavese F, Martelli O, Paris I, Bianchi A, Schinzari G, De Marinis L, Fagotti A, Tortora G, Pontecorvi A. +15 moreeuropepmc +1 more sourceOutbreak of autochthonous West Nile virus infection in Lazio region, Italy, July to August 2025: preliminary investigation. [PDF]
Euro SurveillMussetto I, Bongiovanni A, Colavita F, Giambi C, Sala MG, Del Borgo C, Carletti F, Scicluna MT, Zerbetto A, Corpolongo A, Romiti F, Valli MB, Vaglio S, Giammattei R, Scognamiglio P, De Carli G, Agresta A, De Liberato C, Di Luzio G, Micarelli F, Nicastri E, Siddu A, Ficarelli V, Girardi E, Maggi F, Vairo F, Lazio WNV Outbreak Group, Lazio WNV outbreak group. +27 moreeuropepmc +1 more sourceHypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care? [PDF]
Ann HematolTarantini F, Contento C, Vigna E, Carluccio V, Greco G, Pasciolla C, Ciuffreda L, Rossi G, Urbano MA, D'Ambrosio A, Aprile L, Gagliardi VP, Delia M, Attolico I, Carluccio P, Federico V, Bruzzese A, Di Renzo N, Gentile M, Tarantini G, Mele A, Guarini A, Melillo LMA, Carella AM, Pastore D, Frigeri F, Maggi A, Cumbo C, Specchia G, Musto P, Albano F. +30 moreeuropepmc +1 more sourceTherapy-Related Acute Promyelocytic Leukemia: Case Series and Current Insights. [PDF]
Eur J HaematolBruzzese A, Martino EA, Labanca C, Mendicino F, Lucia E, Olivito V, Morelli R, Rossi T, Neri A, Morabito F, Gentile M, Vigna E. +11 moreeuropepmc +1 more sourceDiscontinuation of combo immunotherapy and outcome of patients with melanoma brain metastases. [PDF]
J Immunother CancerMandalà M, Chen MF, Sullivan RJ, Sergi MC, Postow M, Lawless AR, Effiom D, Peres T, Lorigan PC, Serra-Bellver P, Dummer R, Amaral T, Rasch ML, Giannarelli D, Vitale MG, Helgadottir H, Robert C, Ubaldi M, Johnson DB, Del Vecchio M, Indini A, Suijkerbuijk KPM, Nathan P, Carter T, Neyns B, Dirven I, Pires da Silva I, Menzies AM, Zimmer L, Livingstone E, Depenni R, Kähler K, Hauschild A, Spagnolo F, Di Giacomo AM, Arance A, Merelli B, Quaglino P, Rossi E, Tucci M, Guida M, Muñoz-Couselo E, Long GV, Larkin J, Ascierto PA. +44 moreeuropepmc +1 more sourceImmune Checkpoint Inhibitor-Induced Vitiligo-Like Depigmentation.
JAMA DermatolStarace M, Cedirian S, Rapparini L, Pileri A, Carrera C, Giavedoni P, Alonso de Leon MT, Kraehenbuehl L, Elshot YS, Apalla Z, Papegeorgiou C, Nikolaou V, Radevic T, Lengyel Z, Sollena P, Peris K, Rossi E, Fattore D, Koumaki D, Boada A, Forsea AM, Segura S, Freites-Martinez A, Riganti J, Avitan-Hersh E, Saffuri N, Peuvrel L, Dezoteux F, Piraccini BM, Sibaud V. +29 moreeuropepmc +1 more sourceComparison of isatuximab-pomalidomide-dexamethasone versus elotuzumab-pomalidomide-dexamethasone in relapsed/refractory multiple myeloma patients: a target trial emulation using real-world data. [PDF]
HaematologicaMartino EA, Pitino A, Offidani M, Della Pepa R, Gozzetti A, Bongarzoni V, Maroccia A, Amico V, Stefanoni P, Zamagni E, Terlizzi S, Derudas D, Palmieri S, Bianco R, Conticello C, Brunori M, Rago A, Lotti F, Fontana R, Sgherza N, Rossi E, Cafro AM, Febbo MA, Quinto AM, Cerchione C, Casaluci GM, Citro A, Califano C, Zambello R, Mangiacavalli S, Liberatore C, Buda G, De Magistris C, Amendola A, Vigna E, Bruzzese A, Barbieri E, Quaresima M, Roccotelli D, Farina F, Micozzi J, Vincelli ID, Tarantini G, Antonioli E, Aquino S, Maggi A, Lombardo A, Bertuglia G, Furlan A, Mele A, Annibali O, Cotzia E, Benvenuti P, De Paoli L, Barilà G, Morè S, De Stefano V, Di Raimondo F, Petrucci MT, Bolli N, Musto P, Neri A, Morabito F, Tripepi G, Gentile M. +64 moreeuropepmc +1 more source
